InMed Pharmaceuticals (STU:MWG) Receivables Turnover: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:MWG InMed Pharmaceuticals Inc STU:MWG
28 GF Score
Price €1.19
! 2 Warning Signs
View Full Analysis

What is InMed Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. InMed Pharmaceuticals's Revenue for the three months ended in Jun. 2026 was €0.00 Mil. InMed Pharmaceuticals's average Accounts Receivable for the three months ended in Jun. 2026 was €0.00 Mil.

InMed Pharmaceuticals  (STU:MWG) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

InMed Pharmaceuticals Receivables Turnover Related Terms

InMed Pharmaceuticals Receivables Turnover Historical Data

* Premium members only.

The historical data trend for InMed Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InMed Pharmaceuticals Receivables Turnover Chart

InMed Pharmaceuticals Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.49 24.50 14.97 - -

InMed Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.28 3.15 - -

STU:MWG vs SNOA, GELS, APUS: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, InMed Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InMed Pharmaceuticals Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, InMed Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where InMed Pharmaceuticals's Receivables Turnover falls into.


STU:MWG
28GF Score
InMed Pharmaceuticals Inc STU:MWG
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InMed Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

InMed Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Jun. 2026 is calculated as

Receivables Turnover (A: Jun. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (A: Jun. 2026 ) / ((Accounts Receivable (A: Jun. 2025 ) + Accounts Receivable (A: Jun. 2026 )) / count )
=0 / (( + ) / 1 )
=0 / 0
=N/A

InMed Pharmaceuticals's Receivables Turnover for the quarter that ended in Jun. 2026 is calculated as

Receivables Turnover (Q: Jun. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Jun. 2026 ) / ((Accounts Receivable (Q: Mar. 2026 ) + Accounts Receivable (Q: Jun. 2026 )) / count )
=0 / (( + ) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InMed Pharmaceuticals Business Description

Other Exchanges INM:USA
Address 885 West Georgia Street, Suite 1445, Vancouver, BC, CAN, V6C 3E8
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
28GF Score

Get the complete analysis for STU:MWG

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.19
Price